DTL Is a Prognostic Biomarker and Promotes Bladder Cancer Progression through Regulating the AKT/mTOR axis.

Details

Language :

English

ISSN :

19420900

Database :

Complementary Index

Journal :

Oxidative Medicine & Cellular Longevity

Publication Type :

Academic Journal

Accession number :

154799787

Full Text :

https://doi.org/10.1155/2022/3369858